A Safety and Tolerability Study of ABT-126 in Elderly
NCT00867399
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
ABT-126
Sponsor
Abbott